GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » Net Change in Cash

Nanjing Medlander Medical Technology Co (SHSE:688273) Net Change in Cash : ¥134.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nanjing Medlander Medical Technology Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Nanjing Medlander Medical Technology Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥-4.9 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥134.1 Mil.

Nanjing Medlander Medical Technology Co Net Change in Cash Historical Data

The historical data trend for Nanjing Medlander Medical Technology Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Medlander Medical Technology Co Net Change in Cash Chart

Nanjing Medlander Medical Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial 73.70 47.87 122.30 903.71 -184.21

Nanjing Medlander Medical Technology Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -323.24 37.27 -285.60 387.36 -4.89

Nanjing Medlander Medical Technology Co Net Change in Cash Calculation

Nanjing Medlander Medical Technology Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=136.908+-237.433+-83.689+0.008
=-184.2

Nanjing Medlander Medical Technology Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=4.059+2.634+-11.585+0.002
=-4.9

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥134.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanjing Medlander Medical Technology Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Nanjing Medlander Medical Technology Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Medlander Medical Technology Co (SHSE:688273) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » Net Change in Cash
Comparable Companies
SZSE:301290 SZSE:301515 SHSE:688613 SZSE:300289 SZSE:300642 SHSE:688338 SZSE:300246 SZSE:301033 SZSE:300813 SZSE:301235 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 2, Gande Road, 2nd Floor, Building 5, Jiangning High-tech Park, Jiangning District, Jiangsu Province, Nanjing City, CHN, 211100
Website
http://www.medlander.com
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation.
Executives
Zhu Bi Sheng senior management
Chen Jiang Ning senior management
Yang Rui Jia Directors, senior managers, core technical personn
Shi Zhi Huai Directors, senior managers, core technical personn
Chen Bin Directors, senior managers
Tu Hong Lin Directors, senior managers
Wang Wang senior management

Nanjing Medlander Medical Technology Co (SHSE:688273) Headlines

No Headlines